Government lab unites science journalists

Earlier this week, I and several other editorial staffers here at __The Scientist__ started receiving Emails titled ?User Quarantine Release Notification? from an ?inel.gov? address, presumably from the Idaho National Laboratory. Nothing terribly unusual about such spam, which requested that we click on a link to view a list of all of our quarantined messages. Someone had been attacked by a virus. What happened after that, however, was more unusual: __The New York Times?__ George Johnson respo

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Earlier this week, I and several other editorial staffers here at __The Scientist__ started receiving Emails titled ?User Quarantine Release Notification? from an ?inel.gov? address, presumably from the Idaho National Laboratory. Nothing terribly unusual about such spam, which requested that we click on a link to view a list of all of our quarantined messages. Someone had been attacked by a virus. What happened after that, however, was more unusual: __The New York Times?__ George Johnson responded to the message with a message of his own, saying he was puzzled to be getting the Emails. That made it clear that the original address was actually a group mail address for some kind of list. That list, it turned out, included a number of prominent science writers, some of whom responded to George (and everyone else) and began an electronic conversation: __Time?s__ Michael Lemonick, __The Wall Street Journal?s__ Marilyn Chase, Johnson?s __Times__ colleague Claudia Deutsch, __and Natural History?s__ Peter Brown, among others. ?Nice to meet you? was mixed in with ?We should get matching bowling shirts? and ?WE ARE ALL BEING SPAMMED, SO LET'S PLEASE GET OVER IT AND STOP THE CHAIN OF REPLIES.? One correspondent said he had tried to contact the Idaho lab?s system administrator, to no avail. Government spam, it turns out, can bring together even the most hard-charging reporter competitors.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies